12 February 2024
12 February 2024
CSL’s post-MI drug failed to meet its primary endpoint of reducing the risk of major adverse cardiovascular events.
Plans are in place to extend the dose expansion to include MSS CRC patients in both the US and Asia Pacific regions.
Ensitrelvir led to a decline in the time to resolution of five common symptoms of Covid-19 versus placebo.
Vast quantities of data are only useful to researchers if that data can be easily understood and simply managed. How can artificial intelligence help?
Over the observation period of 56 days in the trial, HMB-001 was found to be well tolerated.
The primary endpoint of the trial will be the Visual Analogue Scale pain relief scores.
The vaccine rollout in 2016 began with relevant schools, community health centres and immunisation clinics.
MIVI presented positive data from the study at the 2024 International Stroke Conference in Phoenix, Arizona, US, on 8 February.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
